4Miller-Blair DJ, Tsuchiya N, Yamaguchi A, et al. Immunologic mechanisms in common rheumatologic diseases. Clin Orthop, 1996,(326) :43-54.
5Malhotra R, Wormald MR, Rudd PM, et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med, 1995,1 (3), 237-243.
6Keusch J, Lydyard PM, Berger EG, et al. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. :Glycoconj J,1998 ; 15(11),1093-1097.
7Bodman-Smith K,Sumar N,Sinclair H, et al. Agalactosyl IgG [Gal (o)]-an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis. Br J Rheumatol, 1996,35 (11 ):1063-1066.
8Alavi A, Arden N,Spector TD,et al. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol, 2000,27(6): 1379-1385
